Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 412

1.

Natural Antibodies: from First-Line Defense Against Pathogens to Perpetual Immune Homeostasis.

Maddur MS, Lacroix-Desmazes S, Dimitrov JD, Kazatchkine MD, Bayry J, Kaveri SV.

Clin Rev Allergy Immunol. 2019 Jun 3. doi: 10.1007/s12016-019-08746-9. [Epub ahead of print] Review.

PMID:
31161341
2.

Passive Serum Therapy to Immunomodulation by IVIG: A Fascinating Journey of Antibodies.

João C, Negi VS, Kazatchkine MD, Bayry J, Kaveri SV.

J Immunol. 2018 Mar 15;200(6):1957-1963. doi: 10.4049/jimmunol.1701271. Review.

3.

Health in the Soviet Union and in the post-Soviet space: from utopia to collapse and arduous recovery.

Kazatchkine MD.

Lancet. 2017 Sep 30;390(10102):1611-1612. doi: 10.1016/S0140-6736(17)32383-8. Epub 2017 Sep 28. No abstract available.

PMID:
28980959
4.

Drug policy and human rights in the Middle East and North Africa: Harm reduction, legal environment and public health.

Himmich H, Kazatchkine MD, Stimson GV.

Int J Drug Policy. 2016 May;31:4-5. doi: 10.1016/j.drugpo.2016.04.008. Epub 2016 Apr 12. No abstract available.

PMID:
27131479
5.

Intravenous immunoglobulin and immune response.

Kaveri SV, Lecerf M, Saha C, Kazatchkine MD, Lacroix-Desmazes S, Bayry J.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:94-6. doi: 10.1111/cei.12526. No abstract available.

6.

Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modeling.

Vickerman P, Platt L, Jolley E, Rhodes T, Kazatchkine MD, Latypov A.

Int J Drug Policy. 2014 Nov;25(6):1163-73.

PMID:
25449056
7.

Natural autoantibodies to Fcγ receptors in intravenous immunoglobulins.

Bouhlal H, Martinvalet D, Teillaud JL, Fridman C, Kazatchkine MD, Bayry J, Lacroix-Desmazes S, Kaveri SV.

J Clin Immunol. 2014 Jul;34 Suppl 1:S4-11. doi: 10.1007/s10875-014-0019-2. Epub 2014 Apr 1.

PMID:
24682714
8.

Affinity-purified respiratory syncytial virus antibodies from intravenous immunoglobulin exert potent antibody-dependent cellular cytotoxicity.

Gupta N, LeGoff J, Chamat S, Mercier-Delarue S, Touzelet O, Power UF, Kazatchkine MD, Simon F, Lacroix-Desmazes S, Bayry J, Kaveri SV.

PLoS One. 2013 Jul 19;8(7):e69390. doi: 10.1371/journal.pone.0069390. Print 2013.

9.

"Rational vaccine design" for HIV should take into account the adaptive potential of polyreactive antibodies.

Dimitrov JD, Kazatchkine MD, Kaveri SV, Lacroix-Desmazes S.

PLoS Pathog. 2011 Jun;7(6):e1002095. doi: 10.1371/journal.ppat.1002095. Epub 2011 Jun 16. Review. No abstract available.

10.

Modulation of HIV Binding to Epithelial Cells and HIV Transfer from Immature Dendritic Cells to CD4 T Lymphocytes by Human Lactoferrin and its Major Exposed LF-33 Peptide.

Carthagena L, Becquart P, Hocini H, Kazatchkine MD, Bouhlal H, Belec L.

Open Virol J. 2011;5:27-34. doi: 10.2174/1874357901105010027. Epub 2011 Apr 15.

11.

Increased resources for the Global Fund, but pledges fall short of expected demand.

Kazatchkine MD.

Lancet. 2010 Oct 30;376(9751):1439-40. doi: 10.1016/S0140-6736(10)61970-8. No abstract available.

PMID:
21036260
12.

Antiangiogenic properties of viscum album extracts are associated with endothelial cytotoxicity.

Elluru SR, Duong Van Huyen JP, Delignat S, Prost F, Heudes D, Kazatchkine MD, Friboulet A, Kaveri SV.

Anticancer Res. 2009 Aug;29(8):2945-50.

13.

Immunointervention for patients with HIV and tuberculosis.

Vani J, Bansal K, Kazatchkine MD, Kaveri SV, Bayry J.

Lancet Infect Dis. 2009 Jun;9(6):332-3. doi: 10.1016/S1473-3099(09)70127-6. No abstract available.

PMID:
19467470
14.

[Intravenous immunoglobulins in autoimmune and inflammatory disorders: beyond a simple substitution].

Galeotti C, Maddur MS, Kazatchkine MD, Mouthon L, Kaveri SV.

Transfus Clin Biol. 2009 May;16(2):75-9. doi: 10.1016/j.tracli.2009.03.009. Epub 2009 May 13. Review. French.

PMID:
19443254
15.

DC-SIGN and alpha2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells.

Bayry J, Bansal K, Kazatchkine MD, Kaveri SV.

Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):E24; author reply E25. doi: 10.1073/pnas.0900016106. Epub 2009 Feb 23. No abstract available.

16.

In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination.

Bayry J, Tchilian EZ, Davies MN, Forbes EK, Draper SJ, Kaveri SV, Hill AV, Kazatchkine MD, Beverley PC, Flower DR, Tough DF.

Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10221-6. doi: 10.1073/pnas.0803453105. Epub 2008 Jul 11.

17.

Modulation of human dendritic cell maturation and function by natural IgG antibodies.

Elluru SR, Vani J, Delignat S, Bloch MF, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV, Bayry J.

Autoimmun Rev. 2008 Jun;7(6):487-90. doi: 10.1016/j.autrev.2008.04.014. Epub 2008 May 7. Review.

PMID:
18558367
18.

Role of natural antibodies in immune homeostasis: IVIg perspective.

Vani J, Elluru S, Negi VS, Lacroix-Desmazes S, Kazatchkine MD, Bayry J, Kaveri SV.

Autoimmun Rev. 2008 Jun;7(6):440-4. doi: 10.1016/j.autrev.2008.04.011. Epub 2008 Apr 28. Review. Erratum in: Autoimmun Rev. 2013 Aug;12(10):1031. Bayary, Jagadeesh [corrected to Bayry, Jagadeesh].

PMID:
18558359
19.

Induction of maturation and activation of human dendritic cells: a mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer.

Elluru SR, Duong van Huyen JP, Delignat S, Kazatchkine MD, Friboulet A, Kaveri SV, Bayry J.

BMC Cancer. 2008 Jun 4;8:161. doi: 10.1186/1471-2407-8-161.

20.

Efficacy of regulatory T-cell immunotherapy: are inflammatory cytokines key determinants?

Bayry J, Lacroix-Desmazes S, Dasgupta S, Kazatchkine MD, Kaveri SV.

Nat Rev Immunol. 2008 Jan;8(1):1p following 86; author reply 1p following 86. No abstract available.

PMID:
18049489
21.

Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+ T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins.

Requena M, Bouhlal H, Nasreddine N, Saidi H, Gody JC, Aubry S, Grésenguet G, Kazatchkine MD, Sekaly RP, Bélec L, Hocini H.

Immunology. 2008 Apr;123(4):508-18. Epub 2007 Nov 10.

22.

Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis.

Ephrem A, Chamat S, Miquel C, Fisson S, Mouthon L, Caligiuri G, Delignat S, Elluru S, Bayry J, Lacroix-Desmazes S, Cohen JL, Salomon BL, Kazatchkine MD, Kaveri SV, Misra N.

Blood. 2008 Jan 15;111(2):715-22. Epub 2007 Oct 11.

23.

Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective.

Sibéril S, Elluru S, Graff-Dubois S, Negi VS, Delignat S, Mouthon L, Lacroix-Desmazes S, Kazatchkine MD, Bayry J, Kaveri SV.

Ann N Y Acad Sci. 2007 Sep;1110:497-506. Erratum in: Ann N Y Acad Sci. 2014 Nov;1330(1):121. Ann N Y Acad Sci. Bayary, Jagadeesh [corrected to Bayry, Jagadeesh].

PMID:
17911465
24.

Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.

Sibéril S, Elluru S, Negi VS, Ephrem A, Misra N, Delignat S, Bayary J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV.

Transfus Apher Sci. 2007 Aug;37(1):103-7. Epub 2007 Aug 31. Review.

PMID:
17765663
25.

Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview.

Lert F, Kazatchkine MD.

Int J Drug Policy. 2007 Aug;18(4):255-61. Epub 2007 Jul 17. Review.

26.

A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes.

Dasgupta S, Navarrete AM, Bayry J, Delignat S, Wootla B, André S, Christophe O, Nascimbeni M, Jacquemin M, Martinez-Pomares L, Geijtenbeek TB, Moris A, Saint-Remy JM, Kazatchkine MD, Kaveri SV, Lacroix-Desmazes S.

Proc Natl Acad Sci U S A. 2007 May 22;104(21):8965-70. Epub 2007 May 14.

27.

[Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].

Graff-Dubois S, Sibéril S, Elluru S, Negi VS, Delignat S, Mouthon L, Lacroix-Desmazes S, Kazatchkine MD, Bayary J, Kaveri SV.

Transfus Clin Biol. 2007 May;14(1):63-8. Epub 2007 May 10. Review. French.

PMID:
17498995
28.

Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.

Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV.

Nat Clin Pract Rheumatol. 2007 May;3(5):262-72. Review.

PMID:
17471245
29.

Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.

Negi VS, Elluru S, Sibéril S, Graff-Dubois S, Mouthon L, Kazatchkine MD, Lacroix-Desmazes S, Bayry J, Kaveri SV.

J Clin Immunol. 2007 May;27(3):233-45. Epub 2007 Mar 11. Review.

PMID:
17351760
30.

Shortage of human intravenous immunoglobulin--reasons and possible solutions.

Bayry J, Kazatchkine MD, Kaveri SV.

Nat Clin Pract Neurol. 2007 Mar;3(3):120-1. No abstract available.

PMID:
17342189
31.

Opsonization of HIV with complement enhances infection of dendritic cells and viral transfer to CD4 T cells in a CR3 and DC-SIGN-dependent manner.

Bouhlal H, Chomont N, Réquena M, Nasreddine N, Saidi H, Legoff J, Kazatchkine MD, Bélec L, Hocini H.

J Immunol. 2007 Jan 15;178(2):1086-95.

32.

Early archives of genetically-restricted proviral DNA in the female genital tract after heterosexual transmission of HIV-1.

Chomont N, Hocini H, Grésenguet G, Brochier C, Bouhlal H, Andréoletti L, Becquart P, Charpentier C, de Dieu Longo J, Si-Mohamed A, Kazatchkine MD, Bélec L.

AIDS. 2007 Jan 11;21(2):153-62.

PMID:
17197805
33.

Increased polymorphism in the HR-1 gp41 env gene encoding the enfuvirtide (T-20) target in HIV-1 variants harboring multiple antiretroviral drug resistance mutations in the pol gene.

Si-Mohamed A, Piketty C, Tisserand P, LeGoff J, Weiss L, Charpentier C, Kazatchkine MD, Bélec L.

J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):1-5.

PMID:
17075396
34.

Comparative study of the anti-inflammatory effect of two intravenous immunoglobulin preparations manufactured by different processes.

Elluru S, Duong Van Huyen JP, Prost F, Delignat S, Bayry J, Ephrem A, Siberil S, Misra N, Lacroix-Desmzes S, Kazatchkine MD, Kaveri SV.

Immunol Lett. 2006 Sep 15;107(1):58-62. Epub 2006 Aug 22. Erratum in: Immunol Lett. 2006 Nov 15;107(2):182.

PMID:
16952403
35.

Molecular mechanisms underlying the immunomodulatory effects of mistletoe (Viscum album L.) extracts Iscador.

Elluru S, Duong Van Huyen JP, Delignat S, Prost F, Bayry J, Kazatchkine MD, Kaveri SV.

Arzneimittelforschung. 2006 Jun;56(6A):461-6. Review.

PMID:
16927527
36.

Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII.

Lacroix-Desmazes S, Wootla B, Dasgupta S, Delignat S, Bayry J, Reinbolt J, Hoebeke J, Saenko E, Kazatchkine MD, Friboulet A, Christophe O, Nagaraja V, Kaveri SV.

J Immunol. 2006 Jul 15;177(2):1355-63.

37.

Alteration of cytochrome oxidase subunit I labeling is associated with severe mitochondriopathy in NRTI-related hepatotoxicity in HIV patients.

Duong Van Huyen JP, Batisse D, Heudes D, Belair MF, Piketty C, Gonzalez-Canali G, Weiss L, Kazatchkine MD, Bruneval P.

Mod Pathol. 2006 Oct;19(10):1277-88. Epub 2006 Jun 30.

38.

Physiopathology of catalytic antibodies: the case for factor VIII-hydrolyzing immunoglobulin G.

Wootla B, Dasgupta S, Mallet V, Kazatchkine MD, Nagaraja V, Friboulet A, Kaveri SV, Lacroix-Desmazes S.

Blood Coagul Fibrinolysis. 2006 Jun;17(4):229-34. Review.

PMID:
16651863
39.

Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms.

Bayry J, Dasgupta S, Misra N, Ephrem A, Duong Van Huyen JP, Delignat S, Hassan G, Caligiuri G, Nicoletti A, Lacroix-Desmazes S, Kazatchkine MD, Kaveri S.

Int Immunopharmacol. 2006 Apr;6(4):528-34. Epub 2005 Dec 9. Review. Erratum in: Int Immunopharmacol. 2013 Jun;16(2):342. Bayary, Jagadeesh [corrected to Bayry, Jagadeesh].

PMID:
16504915
40.

Pathophysiology of catalytic antibodies.

Lacroix-Desmazes S, Wootla B, Delignat S, Dasgupta S, Nagaraja V, Kazatchkine MD, Kaveri SV.

Immunol Lett. 2006 Feb 28;103(1):3-7. Epub 2005 Nov 2. Review.

PMID:
16427704
41.

Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma.

Duong Van Huyen JP, Delignat S, Bayry J, Kazatchkine MD, Bruneval P, Nicoletti A, Kaveri SV.

Cancer Lett. 2006 Nov 8;243(1):32-7. Epub 2006 Jan 18.

PMID:
16412563
42.

Intravenous immunoglobulin and dendritic cells.

Misra N, Bayry J, Dasgupta S, Ephrem A, Huyen JP, Delignat S, Hassan G, Caligiuri G, Nicoletti A, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV.

Clin Rev Allergy Immunol. 2005 Dec;29(3):201-5. Review. Erratum in: Clin Rev Allergy Immunol. 2015 Oct;49(2):262. Bayary, Jagadeesh [corrected to Bayry, Jagadeesh].

PMID:
16391394
43.

Amelioration of differentiation of dendritic cells from CVID patients by intravenous immunoglobulin.

Bayry J, Lacroix-Desmazes S, Hermine O, Oksenhendler E, Kazatchkine MD, Kaveri SV.

Am J Med. 2005 Dec;118(12):1439-40. No abstract available.

PMID:
16378810
44.

Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin.

Ephrem A, Misra N, Hassan G, Dasgupta S, Delignat S, Duong Van Huyen JP, Chamat S, Prost F, Lacroix-Desmazes S, Kavery SV, Kazatchkine MD.

Clin Exp Med. 2005 Dec;5(4):135-40. Review.

PMID:
16362793
45.
46.

High seroprevalence of herpes simplex virus type 2 infection in French human immunodeficiency virus type 1-infected outpatients.

Andréoletti L, Piednoir E, Legoff J, Brodard V, Beguinot I, Strady C, Rouger C, Piketty C, Si-Mohamed A, Kazatchkine MD, Malkin JE, Bélec L.

J Clin Microbiol. 2005 Aug;43(8):4215-7.

47.

High rate of recurrence of cervical intraepithelial neoplasia after surgery in HIV-positive women.

Heard I, Potard V, Foulot H, Chapron C, Costagliola D, Kazatchkine MD.

J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):412-8.

PMID:
16010162
48.

Natural autoantibodies: immune homeostasis and therapeutic intervention.

Bayry J, Misra N, Dasgupta S, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV.

Expert Rev Clin Immunol. 2005 Jul;1(2):213-22. doi: 10.1586/1744666X.1.2.213.

PMID:
20476935
49.

Response to highly active antiretroviral therapy at 6 months and long-term disease progression in HIV-1 infection.

Grabar S, Le Moing V, Goujard C, Egger M, Leport C, Kazatchkine MD, Weiss L, Costagliola D.

J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):284-92.

PMID:
15980687
50.

Modulation of dendritic cell maturation and function by B lymphocytes.

Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Hermine O, Tough DF, Kaveri SV.

J Immunol. 2005 Jul 1;175(1):15-20. Review.

Supplemental Content

Loading ...
Support Center